AccurKardia

New York, NY · Founded 2019 · Privately Held (backing)

Developer of an ECG (Electrocardiogram)-based diagnostics software platform intended to enhance interpretation of electrocardiogram data for improved detection of cardiovascular and metabolic… AccurKardia is based in New York, NY and was founded in 2019. It has raised $9 million across 1 recorded round; the latest was a $4.1 million seed round in Aug 2022.

Last price · $/share
—
Implied valuation
—
Total raised
$9.0M
Last round
Seed Round
Aug 2022
Cap table — not yet on record

AccurKardia's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AccurKardia with a free account
  • ·Watch AccurKardia: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about AccurKardia

Where does AccurKardia's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across AccurKardia's 1 recorded funding rounds.